Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Turk Pediatri Arsivi|August 18, 2018
Liver transplantation from a live donor to a patient with maple syrup urine disease: Two case reportsAhmet Baştürk, Meryem Keçeli, Halil Erbiş, et al.
Pediatric Transplantation|December 17, 2019
Psychopathology, quality of life, and related factors in pediatric liver transplantation candidates and recipientsMihriban Ünay, Arif Önder, Özge Gizli Çoban, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|October 19, 2022
Intestinal Mucormycosis in a Child With Maple Syrup Urine Disease After Orthotopic Liver TransplantErdem Cebisli, Nazan Ulgen-Tekerek, Oguz Dursun, et al.
AJP Reports|December 3, 2014
Microvillus inclusion disease associated with necrotizing enterocolitis in a premature infantErsin Sayar, Salih Kalay, Aygen Yilmaz, et al.
Pediatric Transplantation|January 2, 2023
Long-term results of liver transplantation for maple syrup urine disease: A single-center experience in TurkeyArzu Aras, Ali Avanaz, Nurel Inan Aydemir, et al.
Inflammatory Bowel Diseases|December 6, 2014
Atypical manifestation of LRBA deficiency with predominant IBD-like phenotypeNina Kathrin Serwas, Aydan Kansu, Elisangela Santos-Valente, et al.
Antiviral Therapy|April 28, 2006
Comparison of two different regimens of combined interferon-alpha2a and lamivudine therapy in children with chronic hepatitis B infectionAydan Kansu, Tümay Doğanci, Sezin A Akman, et al.
The Lancet. Gastroenterology & Hepatology|July 5, 2022
Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trialRichard J Thompson, Henrik Arnell, Reha Artan, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|June 23, 2021
Familial Mediterranean Fever Mutation Analysis in Pediatric Patients With İnflammatory Bowel Disease: A Multicenter StudyNafiye Urgancı, Funda Ozgenc, Zarife Kuloğlu, et al.
JHEP Reports : Innovation in Hepatology|July 17, 2023
Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasisRichard J Thompson, Reha Artan, Ulrich Baumann, et al.
Pageof 6